The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
We develop in vitro systems gathering two key characteristics: (1) they are human based and (2) they recreate the in vivo microenvironment cells experience in the body. Acting as miniaturized tissue surrogates, these models can potentially predict human biological responses to drugs and other molecules. These systems can help speeding up drug development and molecule safety screenings, which translates into safer and faster solutions for patients. Besides, our systems make precision medicine possible, while at the same time, they represent a reliable alternative to animal experiments.
Global fellowships (return phase only)\ European fellowships
Research infrastructure/facilities
AlveoliX facilities are split into two locations specialized in organ-on-chip production (clean room) and R&D respectively. The R&D department is equipped with a BSL2 cell culture lab with O2- and humidity-controlled incubators for modelling hyper- or hypoxic conditions, life cell imaging microscope and fully equipped molecular biology lab. Additionally, we have access to BSL3 cell culture labs (SITEM) and facilities and equipment from the University of Bern including FACS, imaging facilities (life cell and high-resolution imaging, electron microscopy), thermocycler, multiplate reader and capillary Western Blot among others. Through the Bern Biobank, we have access to primary human pulmonary tissue.
Research funding/Resources
AlveoliX participates in numerous scientific consortiums consisting of public and private entities. We are in continuous cooperation within research networks applying for international grants such as ITN or EUROSTARS from the Horizon2020 program, or within national programs as the Swiss National Science Foundation. Those grants represent a significant part of the R&D funding invested in developing lung on chip applications as it is the case of the EUROSTARS – AIM4Doc project. In addition to private capital from investors, AlveoliX’s research contracts with private customers, including pharma companies, also reports a substantial contribution to the R&D funding partition.
Links to non-academic sector
AlveoliX R&D department is located at SITEM, the meeting point for patient-focused innovation, technology development and translational medicine in the capital of Switzerland. This centre, integrated by SMEs, clinicians and academics provides a perfect environment for networking and entrepreneurship, including business mentorship. In addition, as a member of different scientific consortiums, AlveoliX has a broad number of cooperation partners at the academia, headed by the University of Bern; the clinics, at the Inselspital, and industry, which ensures secondment opportunities in different sectors.
Experience hosting international researchers, career development & training programmes, outreach activities
AlveoliX is a young start-up in which 30% of the team is integrated by international researchers from different backgrounds. Researchers actively participate in configuring a personalized carrier development plan, which is agreed upon with their supervisor. Milestones and training areas are set jointly with the supervisor, and achievement of development goals are discussed every 6 months. Training areas and responsibilities include: – Project management, experimental design & data analysis, reporting, coordination and communication with project partners – Identification and handling of potential ethical conflicts in research – Identification and management of intellectual property conflicts – Contribution to internship program innovation and mentorship of students – Outreach activities: o Science dissemination in conferences, website and social media o Organization of open doors days, worskshops and seminars o Article publication in scientific journals
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.